Compare · EW vs NTIC
EW vs NTIC
Side-by-side comparison of Edwards Lifesciences Corporation (EW) and Northern Technologies International Corporation (NTIC): market cap, price performance, sector, and recent activity on the wire.
Summary
- EW operates in Health Care, while NTIC operates in Industrials - the two are in different parts of the market.
- EW is the larger of the two at $50.01B, about 666.7x NTIC ($75.0M).
- NTIC has been more active in the news (14 items in the past 4 weeks vs 7 for EW).
- EW has more recent analyst coverage (25 ratings vs 0 for NTIC).
- Company
- Edwards Lifesciences Corporation
- Northern Technologies International Corporation
- Price
- -
- -
- Market cap
- $50.01B
- $75.0M
- 1M return
- -
- -
- 1Y return
- -
- -
- Industry
- Industrial Specialties
- Industrial Specialties
- Exchange
- NYSE
- NASDAQ
- IPO
- News (4w)
- 7
- 14
- Recent ratings
- 25
- 0
Edwards Lifesciences Corporation
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair and replacement products to treat mitral and tricuspid valve diseases. The company also provides surgical heart valve therapy products, such as pericardial valves for aortic and mitral surgical valve replacement; aortic heart valves; annuloplasty rings; cardiac cannula devices; beating heart mitral valve repair system for the treatment of degenerative mitral regurgitation, as well as various procedure-enabling platforms to advance minimally invasive surgery. In addition, it offers critical care products, such as hemodynamic monitoring systems to measure a patient's heart function and fluid status in surgical and intensive care settings; pulmonary artery catheters; arterial pressure monitoring products, oximetry central venous catheters, as well as monitoring platforms that display a patient's physiological information; and Acumen Hypotension Prediction Index, which alerts clinicians in advance of a patient developing low blood pressure. The company distributes its products through a direct sales force and independent distributors. Edwards Lifesciences Corporation was founded in 1958 and is headquartered in Irvine, California.
Northern Technologies International Corporation
Northern Technologies International Corporation develops and markets rust and corrosion inhibiting products and services in North America, South America, Europe, Asia, the Middle East and internationally. It offers rust and corrosion inhibiting products, such as plastic and paper packaging, liquids, coatings, rust removers, cleaners, diffusers, and engineered solutions designed for the oil and gas industry under the ZERUST brand. The company also provides a portfolio of biobased and certified compostable polymer resin compounds and finished products under the Natur-Tec brand. In addition, it offers on-site and technical consulting for rust and corrosion prevention issues. The company sells its products and services to automotive, electronics, electrical, mechanical, military, retail consumer, and oil and gas markets through direct sales force, network of independent distributors and agents, manufacturer's sales representatives, strategic partners, and joint venture. Northern Technologies International Corporation was founded in 1970 and is headquartered in Circle Pines, Minnesota.
Latest EW
- Edwards Lifesciences Comments on TAVR National Coverage Decision
- Edwards Lifesciences to Present at the Deutsche Bank Healthcare Summit
- SVP, Corporate Controller Dahl Andrew M. sold $49,534 worth of shares (544 units at $91.06), decreasing direct ownership by 4% to 14,868 units (SEC Form 4)
- CVP, EMEACLA Bruls Annette sold $237,907 worth of shares (2,644 units at $89.98), decreasing direct ownership by 13% to 17,984 units (SEC Form 4)
- Edwards Lifesciences Corporation filed SEC Form 8-K: Leadership Update
- CVP, TMTT, Surgical & IHFM Chopra Daveen exercised 31,800 shares at a strike of $72.68 and sold $2,894,440 worth of shares (31,800 units at $91.02) (SEC Form 4)
- CVP, JAPAC Markowitz Wayne sold $113,417 worth of shares (1,240 units at $91.47), decreasing direct ownership by 6% to 20,294 units (SEC Form 4)
- CVP, TAVR Lippis Daniel J. exercised 619 shares at a strike of $72.68 and sold $56,967 worth of shares (619 units at $92.03) as part of a pre-agreed trading plan (SEC Form 4)
- SEC Form S-8 filed by Edwards Lifesciences Corporation
- SEC Form 10-Q filed by Edwards Lifesciences Corporation
Latest NTIC
- President and CEO Ramdas Gautam was granted 43,805 shares, increasing direct ownership by 58% to 118,932 units (SEC Form 4)
- New insider Ramdas Gautam claimed ownership of 75,127 shares (SEC Form 3)
- New insider Haglund Brian James claimed ownership of 1,589 shares (SEC Form 3)
- Northern Technologies International Corporation filed SEC Form 8-K: Leadership Update, Regulation FD Disclosure, Financial Statements and Exhibits
- Northern Technologies International Corporation Announces New President and CEO and Other Key Leadership Appointments
- SEC Form 4 filed by President and CEO Lynch G Patrick
- SEC Form 4 filed by CFO and Corporate Secretary Wolsfeld Matthew C
- Director Nigon Richard was granted 7,426 shares, increasing direct ownership by 16% to 54,574 units (SEC Form 4)
- Director Lee Sunggyu was granted 6,188 shares, increasing direct ownership by 186% to 9,507 units (SEC Form 4)
- Director Kemp Sarah E. was granted 6,188 shares, increasing direct ownership by 38% to 22,458 units (SEC Form 4)